MATERIAL EVENT4598.TTSE

Delta-Fly Pharma: change in major shareholder

Summary

Delta-Fly Pharma, Inc. filed an extraordinary report via EDINET on 2024-10-07 15:00 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100UHXQ ↗ · PDL1.0 · Not investment advice